The following is a summary of “Initial experience with prostatic urethral lift versus enucleation of the prostate: a retrospective comparative study,” published in the November 2023 issue of Urology by Obinata, et al.
For a study, researchers sought to compare the eComparing the Initial Outcomes of Prostate Enucleation with Prostatic Urethral Liftarly outcomes and patient features of prostatic urethral lift (PUL) and bipolar transurethral enucleation of the prostate (TUEB) in treating benign prostatic hyperplasia (BPH) in older people. They looked back at 25 patients with BPH who had PUL between April 2022 and May 2023. It was done at a single hospital. Characteristics of the patient, details of the surgery, and scores for symptoms before and after the surgery were all looked at.
The results were compared to those of a TUEB group (n = 55) that had already been reported. The average age of the people in the PUL group was 74.6 years, and their prostates were 47.5 ml in size. Urinary problems got a lot better after the PUL treatment, especially problems with incomplete emptying (P = 0.041), intermittency (P = 0.005), and weak stream (P = 0.001). The illness scores were higher in the PUL group (P=0.048), and the patients were older (P=0.002) than in the TUEB group.
Some symptoms and the highest flow rate got better with TUEB than with PUL (P = 0.01). However, PUL had a shorter surgery time and fewer problems than TUEB (P<0.001). The early findings show that PUL works and is safe for older people with BPH. Even though TUEB has better results in some ways than PUL, PUL has benefits like faster surgery times and fewer problems. So, PUL is a good choice for older men with BPH who are at high risk.
Source: bmcurol.biomedcentral.com/articles/10.1186/s12894-023-01366-8